Johnson & Johnson

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.

CEO

Joaquin Duato

CEOJoaquin Duato

Employees

131,900

Employees131,900

Headquarters

New Brunswick, New Jersey

HeadquartersNew Brunswick, New Jersey

Founded

1887

Founded1887

Employees

131,900

Employees131,900

JNJ Key Statistics

Market cap

368.60B

Market cap368.60B

Price-Earnings ratio

25.31

Price-Earnings ratio25.31

Dividend yield

3.17%

Dividend yield3.17%

Average volume

8.18M

Average volume8.18M

High today

—

High today—

Low today

—

Low today—

Open price

$153.14

Open price$153.14

Volume

0.00

Volume0.00

52 Week high

$168.85

52 Week high$168.85

52 Week low

$143.13

52 Week low$143.13

JNJ News

TipRanks 23h

Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports

Johnson & Johnson (JNJ) and Merck (MRK) are cutting jobs in China as they face growing competition from domestic rivals resulting from Beijing’s campaign to dri...

Benzinga 6d

This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please...

Seeking Alpha 6d

Eli Lilly follows JNJ in suing govt. over 340B drug-discount program

Eli Lilly (NYSE:LLY) has filed a lawsuit over a U.S. health agency's alleged attempts to block its model for offering rebates for drugs supplied under the gover...

Analyst ratings

50%

of 24 ratings

Buy

50%

Hold

50%

Sell

More JNJ News

TipRanks 7d

Wolfe starts J&J at Outperform, sees growth drivers as ‘best-in-class’

Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson (JNJ) with an Outperform rating and $190 price target The firm expects growth...